Dowling et al. focused on biomarkers of bone disease in myeloma and identified 24 proteins (six of which were downregulated) including complement proteins and extracellular matrix glycoproteins [97], while Zhang et al. found 22 proteins (10 downregulated) [98]. Here, VTN is linked to plasma cell myeloma.